River Point Dental Group And Orthodontics Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3960 River Point Pkwy, Unit A, Sheridan, CO 80110 Phone: 303-781-2340 Fax: 303-648-4962 |
News Archive
Their findings - published in the latest edition of Circulation Research, online July 8 - may lead to a gene therapy alternative to calcium channel blockers and their sometimes severe side effects, but also further interest in the development of gene therapies unique - as in this case - to one particular organ.
Middle school students who are more physically fit make better grades and outperform their classmates on standardized tests, according to a newly published study from a professor at the University of Tennessee, Knoxville.
BioMarin Pharmaceutical Inc. announced today that it has acquired ZyStor Therapeutics, Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement therapies (ERT) for the treatment of lysosomal storage disorders. ZyStor's lead product candidate is ZC-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for Pompe disease.
Results from a large-scale Johns Hopkins study of more than 40 hospitals and 160,000 patients show that when health information technologies replace paper forms and handwritten notes, both hospitals and patients benefit strongly.
Patients were misdiagnosed with pneumonia at an alarming rate when they were readmitted to the hospital shortly after a previous hospitalization for the same illness, according to two Henry Ford Hospital companion studies.
› Verified 5 days ago